Q-Line Biotech Limited
QLINE
Half-yearly results
Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.
- Income
- ₹ crore
Half year ₹ crore YoY Mar 2026 198 — - ₹ crore
Half year ₹ crore Mar 2026 3 - ₹ crore
Half year ₹ crore Mar 2026 201 - Cost structure
- ₹ crore
Half year ₹ crore Mar 2026 23 - ₹ crore
Half year ₹ crore Mar 2026 152 - Exceptional items and tax
- ₹ crore
Half year ₹ crore Mar 2026 48 - ₹ crore
Half year ₹ crore Mar 2026 12 - Profit
- ₹ crore
Half year ₹ crore YoY Mar 2026 35 — - Per share
- ₹ per share
Half year ₹ per share Mar 2026 23.10 - Leverage
Debt to equity
timesHalf year times Mar 2026 0.01x
| ₹ crore | Mar 2026 |
|---|---|
| Income | |
| 198 | |
| Revenue YoY | — |
| 3 | |
| 201 | |
| Cost structure | |
| 23 | |
| 152 | |
| Exceptional items and tax | |
| 48 | |
| 12 | |
| Profit | |
| 35 | |
| Net profit YoY | — |
| Per share | |
| 23.10 | |
| Leverage | |
| Debt to equity | 0.01x |
Latest filed period ends Mar 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 1 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.